SINGAPORE (AP) — SINGAPORE (AP) — Wave Life Sciences Pte. Ltd. (WVE) on Thursday reported a loss of $32.9 million in its second quarter.
On a per-share basis, the Singapore-based company said it had a loss of 25 cents.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.
The biopharmaceutical company posted revenue of $19.7 million in the period, which also fell short of Street forecasts. Four analysts surveyed by Zacks expected $24.8 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on WVE at https://www.zacks.com/ap/WVE
